Recent Finacing
Recent Raise
Emmecell is a clinical-stage biotechnology company developing proprietary magnetic cell delivery technologies to treat corneal disease and other ophthalmic conditions.
Focus Areas
Recent Investors
Funding round
See the team members at Emmecell.
